Cardiovascular Disease Risk in Women With Endometriosis
Recruiting · NCT03746535 · Interventional (participants receive a specific treatment) · Lead sponsor: Yale University
View the official record on ClinicalTrials.gov →Interventions studied
Elagolix
What this trial is about
To test the hypothesis that estrogen suppression impairs endothelial dysfunction in endometriosis.
Who can take part
Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Early Phase 1
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Young women between the ages of 18 and 45 years (Controls);
- Young women between the ages of 18 and 45 years with endometriosis.
Exclusion criteria
- Subjects who smoke
- Subjects who have diabetes,
- Subjects with sleep apnea or BP\>140/90 will be excluded.
- Women with endometriosis and severe acute pain requiring immediate treatment will be excluded.
Where it is running
1 location listed across 1 US state.
- Yale School of Medicine - New Haven, Connecticut, United States